Tahir Amin
speaker
103 appearances
1 recordings
1 series
first heard Jul 2026
last heard 6 Jul
Tahir Amin’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.
Appearances
It could cost a branded pharmaceutical company around about 30 to 40 thousand dollars to file and get a patent.
It costs millions to litigate each one.
And as a competitor, I basically say it's not worth my while trying to battle all the way through all these patents.
And what ends up happening is companies settle.
And usually with some kind of settlement, there's a delay when the competitor can enter because that's the agreement.
So I think we often take as a given that it takes billions to develop a drug.
That is a figure that has been thrown around for almost two decades now.
But I would actually like to reframe that whole argument and saying, how can we know how much these drugs cost to develop when we have never seen the actual figures?
These are non-transparent numbers.
They live in a black box.
It's a guarded commercial secret.
And so really, I think we can say, yes, it does cost a lot of money because obviously testing clinical trials and research will cost money.
But is it the billions that we're often told that then justify all these practices that the industry then uses to be able to, say, charge high prices?
We want more patents.
We want more longer monopolies.
No one knows how to make policy
in this area when you're not actually seeing the evidence.
We're taking the industry's word as gospel.
That's a great example.
I think a lot of diseases which are not profitable in the market or because there's no patent to basically allow a company to profit from it get left by the wayside.
Showing 41–60 of 103 · page 3 of 6
← Previous
Next →